Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4